Latest Breaking News On - Olema pharmaceuticals trading - Page 2 : comparemela.com

Capital One Financial assumed coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) in a research report released on Friday morning, The Fly reports. The firm issued an overweight rating and a $16.00 target price on the stock. Several other brokerages also recently issued reports on OLMA. Credit Suisse Group reduced their price objective […]

Balyasny asset managementInstitutional investors weigh in on olema pharmaceuticalsOlema pharmaceuticals tradingVirtu financialAnalyst recommendations for olema pharmaceuticalsPrelude capital managementOlema pharmaceuticals company profileNews ratings for olema pharmaceuticals dailyTudor investment corp et alCredit suisse groupOlema pharmaceuticalsOlema pharmaceuticals incCapital one financialGet ratingSuisse groupStreet group